Topics › Drug Policy › Ibogaine
Testimony by Madison Carlino
Psychedelics Policy Newsletter by Gregory Ferenstein
Commentary by Gregory Ferenstein
Testimony by Geoffrey Lawrence, Leonard Gilroy and Gregory Ferenstein
Commentary by Layal Bou Harfouch